NCT03471507 is a Phase 2 clinical trial of Bonipar in Chronic Pain, sponsored by Winston Parris, MD.

Who is sponsoring NCT03471507?

NCT03471507 is sponsored by Winston Parris, MD.

What drugs are being tested in NCT03471507?

Interventions in NCT03471507: Bonipar, Diclofenac sodium topical solution 1.5%.

What condition does NCT03471507 study?

NCT03471507 studies Chronic Pain, Musculoskeletal Pain.

Is NCT03471507 still recruiting?

NCT03471507 is currently completed. Last updated 18 September 2023.

Are results published for NCT03471507?

Yes — primary outcome results have been posted to ClinicalTrials.gov. See the outcomes section above for details.

Last reviewed 2023-09-18 · How we verify

NCT03471507

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Bonipar for Acute and Chronic Musculoskeletal Pain

Completed Phase 2 Results posted Last updated 18 September 2023

What this trial tests

Phase 2 trial testing Bonipar in Chronic Pain in 164 participants. Completed in 22 September 2022.

Timeline

15 December 2020

Primary endpoint
22 September 2022

22 September 2022

Quick facts

Lead sponsor	Winston Parris, MD
Phase	Phase 2
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	quadruple
Primary purpose	treatment
Enrollment	164
Start date	15 December 2020
Primary completion	22 September 2022
Estimated completion	22 September 2022
Sites	1 location across United States

Drugs / interventions tested

Bonipar — full drug profile →
Diclofenac sodium topical solution 1.5% — full drug profile →

Conditions studied

Chronic Pain — all drugs for Chronic Pain →
Musculoskeletal Pain — all drugs for Musculoskeletal Pain →

Sponsor

Winston Parris, MD — full company profile →

Who can join

Adults 18 to 80, any sex, with Chronic Pain or Musculoskeletal Pain. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study is a non-inferiority study comparing efficacy and onset of action between the herbal extracts topical solution, Bonipar, and diclofenac sodium topical solution, diclofenac topical solution 1.5%.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Chronic Pain

Currently open trials in the same condition.

NCT07491549 — The Effect of Pain Education Group Therapy and Its Impact on Chronic Pain, Kinesiophobia, and Physical Activity · NA · recruiting
NCT07425691 — SPACE for Youth With Chronic Pain · recruiting
NCT07103135 — Optimizing Accelerated TMS for Chronic Pain With Thompson Sampling · Phase 1 · recruiting
NCT06219408 — CIH Stepped Care for Co-occurring Chronic Pain and PTSD · NA · recruiting
NCT07270406 — Healthy Behaviors for Insomnia Prevention in People With HIV and Ongoing Pain · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03471507 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Winston Parris, MD
Last refreshed: 18 September 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03471507.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing